QuidelOrtho Corporation QDEL China — Cost of sales, excluding amortization of intangibles

Other segment segments

Similar metrics at other companies

VTRSGreater China — Cost of Sales

$70.9M+16.6%

AAPLGreater China — Cost of Sales

$10.63B+20.9%

MTDChinese Operations Segment — Cost of Product and Service Sold

$104.14M+4.7%

LULUChina Mainland — Selling, general and administrative expenses

$111.21M+35.0%

ABTDiagnostic Products — Cost of products sold, excluding amortization of intangible assets

$1.24B+7.8%

DGIIProduct — Cost of sales excluding amortization

$37.77M+18.9%

Questions, answered.

What is QuidelOrtho Corporation's china — cost of sales, excluding amortization of intangibles?

QuidelOrtho Corporation (QDEL) reported china — cost of sales, excluding amortization of intangibles of $32M in Q1 2026.

How has QuidelOrtho Corporation's china — cost of sales, excluding amortization of intangibles changed year-over-year?

QuidelOrtho Corporation's china — cost of sales, excluding amortization of intangibles decreased by 6.4% year-over-year, from $34.2M to $32M.

What is the long-term trend for QuidelOrtho Corporation's china — cost of sales, excluding amortization of intangibles?

Over 3 years (2022 to 2025), QuidelOrtho Corporation's china — cost of sales, excluding amortization of intangibles has grown at a 16.9% compound annual growth rate (CAGR), from $92.5M to $147.6M.

What does china — cost of sales, excluding amortization of intangibles mean?

Captures the direct costs associated with producing and delivering diagnostic products in the China segment, excluding non-cash amortization charges. Monitoring this helps evaluate the direct production efficiency and gross margin performance specific to this regional supply chain.